Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
09/07/1999 | US5948656 Proteins which bind to cytolytic lymphocyte cytoplasmic granule associated rna binding proteins; anticarcinogenic agents; treatment of graft vs. host disease, allograft rejection, transplantation organ rejections |
09/07/1999 | US5948645 Biosynthetic gene muri from Streptococcus pneumoniae |
09/07/1999 | US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome |
09/07/1999 | US5948626 Method of detecting human phospholipase inhibitor |
09/07/1999 | US5948625 Method of screening for ATP synthase Fo subunit |
09/07/1999 | US5948622 System for in vitro transposition |
09/07/1999 | US5948614 Free of exonuclease activity and non-discriminating against dideoxynucleotides; more heat resistant than thermus polymerase; for sequence determination, amplification, and complementary dna synthesis |
09/07/1999 | US5948612 Biological screens for detection of herbicides |
09/07/1999 | CA2128795C A virus-safe blood coagulation factor xiii preparation |
09/07/1999 | CA2026041C Deacetoxycephalosporin c hydroxylase |
09/07/1999 | CA2012025C Dna for expression and secretion |
09/07/1999 | CA1340723C Production of exogenous peptide in milk |
09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
09/02/1999 | WO1999043838A1 Synthetic promoters |
09/02/1999 | WO1999043835A2 Methods for producing a polypeptide in a bacillus cell |
09/02/1999 | WO1999043834A2 P-selectin ligand protein, including tetrameric fusion proteins |
09/02/1999 | WO1999043833A1 Disease resistant transgenic plants |
09/02/1999 | WO1999043832A2 Human proteinase molecules |
09/02/1999 | WO1999043831A1 Cprot03, a human cysteine protease |
09/02/1999 | WO1999043830A2 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity |
09/02/1999 | WO1999043829A2 Cell cycle related proteins |
09/02/1999 | WO1999043828A1 Human homolog of the drosophila protein 'fused' |
09/02/1999 | WO1999043827A1 Cyclopropane-fatty-acyl-phospholipid synthase |
09/02/1999 | WO1999043826A1 A gene involved in thiophene degradation from nocardia asteroides kgb1 |
09/02/1999 | WO1999043825A1 Plant flavanone-3-hydroxylase |
09/02/1999 | WO1999043822A1 Nitric oxide as an activator of the plant pathogen defense systems |
09/02/1999 | WO1999043809A2 Protease-activated receptor 4 and uses thereof |
09/02/1999 | WO1999043797A2 Constitutive maize promoters |
09/02/1999 | WO1999043796A1 Methods of using a pathogen-activatable map kinase to enhance disease resistance in plants |
09/02/1999 | WO1999043795A1 Trans-somatics with gene transfer into mammary epithelial cells |
09/02/1999 | WO1999043794A1 Maltogenic alpha-amylase variants |
09/02/1999 | WO1999043793A1 Amylolytic enzyme variants |
09/02/1999 | WO1999043792A1 Recombinant protein having rna-dependent polymerase activity of human hepatitis c virus and process for producing the same |
09/02/1999 | WO1999043791A2 Diisopropyl fluorophosphatase and the utilization and production thereof |
09/02/1999 | WO1999043704A1 A NOVEL INHIBITOR OF THE INFLAMMATORY RESPONSE INDUCED BY TNFα AND IL-1 |
09/02/1999 | WO1999043697A1 Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms |
09/02/1999 | WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
09/02/1999 | WO1999043346A1 Methods for diagnosing and treating autoimmune disease |
09/02/1999 | WO1999043338A1 Antibacterial drugs, methods for their design and methods for their use |
09/02/1999 | WO1999033958A3 Desaturase |
09/02/1999 | WO1999028485A3 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes |
09/02/1999 | WO1999028453A3 Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |
09/02/1999 | WO1999020770A3 Multiply-substituted protease variants |
09/02/1999 | WO1999020727A9 Cleaning compositions containing multiply-substituted protease variants |
09/02/1999 | WO1999020723A9 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
09/02/1999 | CA2759907A1 Maltogenic alpha-amylase variants |
09/02/1999 | CA2354228A1 Plants and seeds containing synthetic promoters |
09/02/1999 | CA2321959A1 Methods for diagnosing and treating autoimmune disease |
09/02/1999 | CA2321870A1 Cell cycle related proteins |
09/02/1999 | CA2321869A1 Human proteinase molecules |
09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
09/02/1999 | CA2320813A1 Amylolytic enzyme variants |
09/01/1999 | EP0939135A1 Substantially pure hetero-bicyclic alcohol enantiomers |
09/01/1999 | EP0939132A1 Preparation of optically active alcohol substituted with one or more halogen atoms |
09/01/1999 | EP0939131A2 Aminopeptidases |
09/01/1999 | EP0939130A1 Rna polymerase |
09/01/1999 | EP0939129A1 Increase of nodule number and nitrogen fixation in leguminosae |
09/01/1999 | EP0939125A2 Expression vector for the conditional regulation of expression of the large subunit of polymerase II |
09/01/1999 | EP0938584A2 Method of preparing (s) - or (r) -3,3,3-trifluoro-2-hydroxy-2- methylpropionic acid |
09/01/1999 | EP0938582A1 Enzymatic process for the manufacture of ascorbic acid, 2-keto-l-gulonic acid and esters of 2-keto-l-gulonic acid |
09/01/1999 | EP0938573A2 Plant cellulose synthase and promoter sequences |
09/01/1999 | EP0938570A1 MUTANT $g(a)-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN $i(BACILLUS LICHENIFORMIS) |
09/01/1999 | EP0938568A1 Plant phytases and biotechnological applications |
09/01/1999 | EP0938567A1 Applications for regulatory region of nos isoforms |
09/01/1999 | EP0938566A2 Metabolically engineered lactic acid bacteria and means for providing same |
09/01/1999 | EP0938565A2 Vaccine compositions |
09/01/1999 | EP0938555A1 Constructs and complexes of cyclin e |
09/01/1999 | EP0938554A1 Human protein kinase c inhibitor homolog |
09/01/1999 | EP0938552A1 Site-specific mutagenesis and mutant selection utilizing antibiotic-resistant markers encoding gene products having altered substrate specificity |
09/01/1999 | EP0938551A1 Ku DEFICIENT CELLS AND NON-HUMAN TRANSGENIC ANIMALS |
09/01/1999 | EP0938548A1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof |
09/01/1999 | EP0938547A1 Modified ligands of calcium-dependent binding proteins |
09/01/1999 | EP0938546A1 Hppd gene and inhibitors |
09/01/1999 | EP0938541A1 CELLULASE OBTAINABLE FROM $i(THERMOMONOSPORA FUSCA) FOR USE IN INDUSTRIAL PROCESSES |
09/01/1999 | EP0938495A1 Compounds which prevent neuronal cell death and uses thereof |
09/01/1999 | CN1227608A Transcriptional silencing elements and their binding factors |
09/01/1999 | CN1227606A Purified proteins, recombinant DNA sequences and processes for controlling the ripening of coffee plants |
09/01/1999 | CN1227264A Method of producing L-serine by fermentation |
09/01/1999 | CN1227263A Method of producing L-serine by fermentation |
08/31/1999 | US5945585 Specific for palmitoyl, stearoyl and oleoyl-alp thioesters nucleic acid fragments encoding acyl-acp thiosesterase enzymes and the use of these fragments in altering plant oil composition |
08/31/1999 | US5945581 Implanting disease resistance to plants with viral replicase DNA molecules which do not have a read-through portion |
08/31/1999 | US5945580 Capsicum hemicellulase polynucleotides and polypeptides |
08/31/1999 | US5945539 Enzyme inhibitor |
08/31/1999 | US5945520 Chromatographic resins and methods for using same |
08/31/1999 | US5945512 An antibody against amino-terminated peptide for the detection of diabetic vascular disorders |
08/31/1999 | US5945452 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
08/31/1999 | US5945403 Angiostatin fragments and method of use |
08/31/1999 | US5945401 Polypeptides as antidiabetic agents |
08/31/1999 | US5945339 Genetic engineering |
08/31/1999 | US5945329 Mutant carboxypeptidase y with modified active sites able to catalyze tranacylation of preselected peptide substrate with preselected nucleophile; for post-translational modification of recombinant peptides |
08/31/1999 | US5945328 Process for producing trypsin (trypsinogen) |
08/31/1999 | US5945327 DNA constructs and methods of producing cellulytic enzymes |
08/31/1999 | US5945326 Culturing transformed vector; gene expression, genetic engineering |
08/31/1999 | US5945325 Mutant enzyme with specific amino acid substitutions isolated from library; for deblocking, deprotecting beta-lactam antibiotics |
08/31/1999 | US5945324 A cdna molecule; for identifying new fungicide compounds |
08/31/1999 | US5945323 DNA encoding a 2-acyltransferases |
08/31/1999 | US5945322 Several open reading frames from neisseria gonorrhoeae; for diagnosis and bactericides; for probes and primers |
08/31/1999 | US5945321 Ubiquitin conjugating enzymes 7, 8 and 9 |
08/31/1999 | US5945320 A dna molecule that codes a protein; for screening of new antibiotics |